Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Goodbody Health Ltd GDBYF

Goodbody Health Ltd is a wellness company operating in both COVID testing in the United Kingdom and as a vertically integrated cannabinoid CBD company that operates in the United Kingdom and the European Union. It has interests in COVID testing clinics, CBD extraction, wholesale bulk isolate, and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs.


GREY:GDBYF - Post by User

Comment by lscfaon Apr 21, 2020 10:30pm
118 Views
Post# 30937243

RE:Trouble in Paradise?

RE:Trouble in Paradise?If wholesale prices of CBD in Europe have tanked like Stillcanna claims then Dragonfly probably want to renege on the minimum purchase price.

"As of the date of this report, BCI has reached a definitive shareholders’ agreement with DragonFly  Biosciences (UK) LLC. (“DFB”) to form an exclusive joint venture (“JV”) company – i.e., named  Premium Extractions, Inc. (“PEI”).

The shareholders’ agreement sets out that PEI is owned 49% by  BCI and 51% by DFB. The shareholders’ agreement also sets out that DFB is:

(a) contributing  continuous longterm access to its hemp crops;

(b) will provide certain processing equipment;

(c)  its growing expertise; and

(d) a takeup agreement with PEI to purchase a minimum of 50,000  grams of CBD per month at 2 Euros per gram.

The shareholders’ agreement also sets out that BCI  will provide:

(a) PEI access to use its Extraction System;

(b) capital to fund the development of PEI’s initial Romanian extraction facility located near the Bulgaria/Romania border. and

(c) BCI’s  operational extraction management capabilities as well as capital markets expertise.     
 





Mike660 wrote: Captured this tidbit of information in the Sativa Acquisition announcement. Seems like partnership problems with Dragonfly
"Stillcanna is pleased that its subsidiary, Borganic Consulting Inc, has secured all licenses and permits required for its ORIGIN extraction facility in Romania to commence the manufacturing of CBD. The facility was constructed through a joint venture partnership with Dragonfly Biosciences Limited of the UK. Even though Borganic Consulting remains dedicated to the ORIGIN extractionfacility it has become concerned with the behaviour of its partner Dragonfly Biosciences. In order to secure the future of the ORIGIN extraction facility and its investment to date, Borganic Consulting has initiated legal action in the UK against Dragonfly Biosciences for contractual breaches under the partnership agreement and Stillcanna is confident that Borganic Consulting will be able to resolve these issues in a timely manner. Regardless of this action, Stillcanna and Borganic Consulting will continue towards the commencement of manufacturing CBD at the ORIGIN facility as soon as possible."


<< Previous
Bullboard Posts
Next >>